EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective

Rumiana Tenchov iD, Janet M Sasso iD, Qiongqiong Angela Zhou iD

Bioconjugate Chemistry · 21.06.2023 · 34 (6) · 941-960

DOI: 10.1021/acs.bioconjchem.3c00174 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioconjugate Chemistry, online erschienen am 10.05.2023. Verfasst von Rumiana Tenchov und 2 weiteren Autor:innen. Beteiligte Einrichtung: CAS, a division of the American Chemical Society, 2540 Olentangy River Road, Columbus, Ohio 43202, United States. Hauptthemen laut MEDLINE: COVID-19, Nanoparticles. Die Arbeit wurde bisher 339-mal zitiert (Crossref) und nennt 241 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) have been recognized as efficient vehicles to transport a large variety of therapeutics. Currently in the spotlight as important constituents of the COVID-19 mRNA vaccines, LNPs play a significant role in protecting and transporting mRNA to cells. As one of their key constituents, polyethylene glycol (PEG)-lipid conjugates are important in defining LNP physicochemical characteristics and biological activity. PEGylation has proven particularly efficient in conferring longer systemic circulation of LNPs, thus greatly improving their pharmacokinetics and efficiency. Along with revealing the benefits of PEG conjugates, studies have revealed unexpected immune reactions against PEGylated nanocarriers such as accelerated blood clearance (ABC), involving the production of anti-PEG antibodies at initial injection, which initiates accelerated blood clearance upon subsequent injections, as well as a hypersensitivity reaction referred to as complement activation-related pseudoallergy (CARPA). Further, data have been accumulated indicating consistent yet sometimes controversial correlations between various structural parameters of the PEG-lipids, the properties of the PEGylated LNPs, and the magnitude of the observed adverse effects. Detailed knowledge and comprehension of such correlations are of foremost importance in the efforts to diminish and eliminate the undesirable immune reactions and improve the safety and efficiency of the PEGylated medicines. Here, we present an overview based on analysis of data from the CAS Content Collection regarding the PEGylated LNP immunogenicity and overall safety concerns. A comprehensive summary has been compiled outlining how various structural parameters of the PEG-lipids affect the immune responses and activities of the LNPs, with regards to their efficiency in drug delivery. This Review is thus intended to serve as a helpful resource in understanding the current knowledge in the field, in an effort to further solve the remaining challenges and to achieve full potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NanoparticlesHumansLiposomesPolyethylene GlycolsLipids

Substanzen

Lipid NanoparticlesLiposomesPolyethylene GlycolsLipids

Autor:innen und Institutionen

  • CAS, a division of the American Chemical Society, 2540 Olentangy River Road, Columbus, Ohio 43202, United States.

ORCID-Profile: Rumiana Tenchov, Janet M Sasso, Qiongqiong Angela Zhou

Zitieren

APA

Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2023). PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective. Bioconjugate Chemistry, 34(6), 941-960. https://doi.org/10.1021/acs.bioconjchem.3c00174

Vancouver

Tenchov R, Sasso JM, Zhou QA. PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective. Bioconjugate Chemistry. 2023;34(6):941-960. doi:10.1021/acs.bioconjchem.3c00174

BibTeX
@article{Tenchov2023,
  author = {Tenchov, Rumiana and Sasso, Janet M and Zhou, Qiongqiong Angela},
  title = {PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective},
  journal = {Bioconjugate Chemistry},
  year = {2023},
  volume = {34},
  number = {6},
  pages = {941--960},
  doi = {10.1021/acs.bioconjchem.3c00174}
}
Kostenlos starten →